GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • American Association for Cancer Research (AACR)  (18)
  • 1
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 13_Supplement ( 2017-07-01), p. 1770-1770
    Abstract: Background: Sarcopenia is a syndrome that is characterized by progressive and generalized loss of skeletal muscle mass and strength. Several recent studies have shown that sarcopenia has prognostic significance for patients with malignant disease, including cancers of the esophagus, colon, pancreas and liver. On the other hand, cellular senescence is gaining increased attention from clinicians and researchers, yet incompletely understood role in the development of malignant disease. Previous studies reported that Caveolin-1 expression in cancer associated fibroblast is associated with cancer progression, and it is known in recent years that caveolin-1 plays a major role in controlling cellular senescence. Therefore, we hypothesized that sarcopenia causes cellular senescence of cancer associated fibroblast (CAF). The aim of this study is to clarify the between sarcopenia and cellular senescence of CAF through Caveolin-1 in pancreatic cancer. Methods: All consecutive patients with pancreatic cancer underwent curative resection between January 2004 and December 2014 were enrolled in this retrospective study. Skeletal muscle and visceral fat amount at the third lumbar vertebra (L3) in the inferior direction were quantified using enhanced computed tomography. The patients were divided into two groups, with and without sarcopenia, based on Japan Society of Hepatology guidelines for sarcopenia. Next, Caveolin-1 expression was analyzed by immunohistochemistry (IHC). Moreover, we investigated the relationship between sarcopenia and Caveolin-1 expression. Results: Forty-one (31.5%) of 130 patients were identified with sarcopenia. Kaplan-Meier analysis showed that patients with sarcopenia had a significantly worse cancer specific survival than patients without sarcopenia (3-year-survival: 37.2% vs 50.4%, respectively, p = 0.038). While, a high level of Caveolin-1 expression was detected in 29.2% (38/130) of our samples. High Caveolin-1 expression in CAF significantly correlated with poor prognoses with respect to overall survival (log-rank p = 0.014) and disease-free survival (log-rank p = 0.0015). However, there was no relationship between sarcopenia and IHC score of Caveolin-1 expression in CAF. Conclusion: The present result suggested that sarcopenia and Caveolin-1 expression of CAF in patient with pancreatic cancer is respectively associated with poor prognosis, but not associated each other. Now, we focus on Caveolin-1 expression of CAF, and establish primary cultures of CAF from the pancreatic cancer tissues and examine its function. Citation Format: Kensuke Yamamura, Yo-ichi Yamashita, Yuki Kitano, Kota Arima, Takayoshi Kaida, Tatsunori Miyata, Shigeki Nakagawa, Kosuke Mima, Katsunori Imai, Daisuke Hashimoto, Akira Chikamoto, Hideo Baba. The association between sarcopenia and cellular senescence of cancer associated fibroblast in pancreatic cancer [abstract] . In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1770. doi:10.1158/1538-7445.AM2017-1770
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 5350-5350
    Abstract: Background: Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the polycomb repressive complex 2 (PRC2). When present in PRC2, EZH2 catalyzes trimethylation on lysine 27 residue of histone H3(H3K27Me3), resulting in epigenetic silencing of gene expression and cancer progression. Here, we investigated the expression and the function of EZH2 in intrahepatic and extrahepatic cholangiocarcinoma (ICC and ECC). Methods: The influence of EZH2 on cell growth and apoptosis was assessed by knockdown experiments using siRNA in cholangiocarcinoma cell lines, RBE and TFK-1. Target genes of EZH2 in cholangiocarcinoma cell lines were searched by real time PCR. The clinical significance of EZH2 in 84 cholangiocarcinoma patients (ICC and ECC in 45 and 41, respectively) who underwent a curative surgery was examined by immunohistochemistry. Results: In vitro analysis, a knockdown of EZH2 reduced cell growth and induced G1 arrest, and induced apoptosis confirmed by Annexin V staining and increasing sub-G1 population of two cholangiocarcinoma cell lines. Moreover, a knockdown of EZH2 increased the expression of p16INK4A and p27KIP1, in real time PCR. In immunohistochemical study, The upregulation of EZH2 was correlated with tumor diameter (P = 0.0103) in ICC, lymph node metastasis (P=0.0292) in ECC, and Ki67 index in both ICC (P=0.0364) and ECC (P=0.0017). In addition, EZH2 expression was correlated with the poor prognosis in both ICC (P=0.0447) and ECC (P=0.0227). Conclusion: The current study demonstrates that the high expression of EZH2 results in acceleration of cell cycle and anti-apoptosis in vitro analysis, and is related to poor prognosis in patients with ICC or ECC by IHC study. These results suggest that EZH2 is a potential target for cholangiocarcinoma therapeutics. Citation Format: Shigeki Nakagawa, Hirohisa Okabe, Yasuo Sakamoto, Hiromitsu Hayashi, Daisuke Hashimoto, Hideyuki Kuroki, Katsunori Imai, Hidetoshi Nitta, Akira Chikamoto, Masayuki Watanabe, Toru Beppu, Hideo Baba. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma by regulating cell cycle and apoptosis. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5350. doi:10.1158/1538-7445.AM2013-5350
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 74, No. 19_Supplement ( 2014-10-01), p. 2700-2700
    Abstract: Background Worldwide, while a hepatectomy has been performed as the curative procedure for liver cancers, a failure in liver regeneration following hepatectomy can result in functional liver disorders and hepatic failure. Therefore, a novel therapeutic strategy to accelerate liver regeneration enables to undergo safety curative hepatectomy for liver cancers. Transforming growth factor-β1 (TGF-β1) is a potent inhibitor of mitogen-stimulated DNA synthesis in hepatocyte. Since TGF-β is synthesized and secreted as a latent complex, an important step in regulating its biological activity is the conversion of the latent form into the active one. We reported that matricellular protein thrombospondin-1 (TSP-1), a major activator of latent TGF-β1 is a negative regulator of liver regeneration after hepatectomy using TSP-1 null mouse. In response to partial hepatectomy, TSP-1 production is acutely and transiently induced in the endothelial cells of the regenerative liver. These findings indicate the possibility of a novel therapeutic strategy for accelerating liver regeneration by targeting TSP-1 mediated TGF-β1 activation. This study aimed to clarify whether LSKL peptide, inhibiting TSP-1-mediated TGF-β activation, promoted liver regeneration after hepatectomy in mice. Method We performed 70% hepatectomy in mice receiving normal saline, LSKL peptide, and sham operation. LSKL peptide was administered intraperitoneally at abdominal closure and 6 h after hepatectomy. LSKL peptide (30 mg/6 mL/kg) was intraperitoneally administered before abdominal wall closure and at 6 h after 70% hepatectomy. Mice received an intraperitoneal injection of 5-bromo-2-deoxyuridine (BrdU), a marker for the S-phase of the cell cycle ,2 h prior to sacrifice. Result LSKL peptide administration attenuated Smad2 phosphorylation at 6 h after hepatectomy and thereafter accelerated S-phase entry of hepatocytes at 24 and 48 h. The accelerated hepatocyte proliferation by LSKL peptide administration resulted in faster recovery of the residual liver weight at 48 h and body weight at 168 h. H & E staining and blood biochemical examinations revealed no significant adverse effects occurred following the two LSKL peptide administrations during the early period after hepatectomy. Conclusion Only two doses of LSKL peptide during the early period after partial hepatectomy can promote liver regeneration and body weight recovery without any significant side effects. The transient inhibition of TGF-β signal activation in the early period after hepatectomy was sufficient for accelerating hepatocyte. Inhibiting TSP-1-medaited TGF-β activation using LSKL peptide may thus be a promising strategy to promote liver regeneration following hepatectomy. Citation Format: Hideyuki Kuroki, Hiromitsu Hayashi, Shigeki Nakagawa, Keita Sakamoto, Takaaki Higashi, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Toru Beppu, Hideo Baba. LSKL peptide inhibits thrombospondin-1-mediated TGF-β signal activation and accelerates liver regeneration after hepatectomy in mice. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2700. doi:10.1158/1538-7445.AM2014-2700
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2014
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 13_Supplement ( 2017-07-01), p. 1920-1920
    Abstract: Background: Chronic inflammation is known to be a risk factor of carcinogenesis and tumor development, and it was demonstrated that oral aspirin intake reduced cancer-related death including pancreatic ductal adenocarcinoma (PDAC) through inhibiting prostaglandin synthases. On the other hand, cancer stem cells (CSCs) refer to a subset of tumor cells that have self-renewal ability and generate plenty of non-CSC cells that comprise a tumor. Prostaglandin E2 (PGE2) and inhibition of 15-PGDH, which is an enzyme degrading PGE2, promoted hematopoietic and tissue stem cell fraction, however, little is known about the role of PGE2 accumulation for CSC fraction. A number of CSC marker candidates have been explored to date, and Aldehyde dehydrogenase 1 (ALDH1) was identified as one of CSC markers in PDAC. The aim of this study is to elucidate the functional role of PGE2 in ALDH1 positive CSC fraction during tumor development in pancreas. Methods: The clonogenic growth potential of ALDH1-positive PDAC cells was assessed in vitro by growth assays and sphere formation assays. We next investigated the expression of ALDH1 and self-renewal related genes in PDAC cell lines with PGE2 or 15-PGDH inhibitor treatment. We further conducted functional experiments using siALDH1 in PDAC progression. Furthermore, we examined the effect of PGE2 for pancreatic tumorigenesis using Kras-driven genetic mouse model treated with 15-PGDH inhibitor. Finally, ALDH1 and Ki67 expression was examined by immunohistochemistry in 121 primary surgical specimens of PDAC and analyzed a relationship with clinicopathological factors and clinical outcomes. Results: The number of ALDH1-positive cells was significantly increased by PGE2 treatment, and PGE2 promoted growth and sphere formation potential in PDAC cells. In addition, 15-PGDH inhibitor induced PGE2 accumulation and gave rise to ALDH1-positive cells harboring high proliferating potential in PDAC cells. The growth and sphere formation potential were inhibited by silencing ALDH1 expression in PDAC cells. We next found that the expression of Nanog and Oct-4 genes was regulated by PGE2-ALDH1 signaling. Furthermore, 15-PGDH inhibitor induced ALDH1 expression and promoted PanIN formation in Kras-driven genetic mouse model. Finally, a high level of ALDH1 expression was significantly associated with large tumor size and high Ki67expression, and poor prognosis in PDAC patients. Conclusion: Current findings suggested that PGE2 positively regulated ALDH1 expression, and the growth and sphere formation potential were promoted by regulating self-renewal related genes expression, resulting in poor prognosis of PDAC patients. Inhibiting PGE2-ALDH1 signaling could lead to the suppression of tumor growth in PDAC patients. Citation Format: Kota Arima, Takatsugu Ishimoto, Masaki Ohmuraya, Keisuke Miyake, Tsugio Eto, Hirohisa Okabe, Yuki Kitano, Kensuke Yamamura, Takayoshi Kaida, Katsunori Imai, Daisuke Hashimoto, Akira Chikamoto, Hideo Baba. Prostaglandin E2 accumulation enhances the expansion of ALDH1-positive cells and Kras-driven tumorigenesis in the pancreas [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1920. doi:10.1158/1538-7445.AM2017-1920
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 15_Supplement ( 2015-08-01), p. 1175-1175
    Abstract: Background: Cancer metabolism is a new and exciting field of biology that provides a fundamentally different approach to treating cancer. The characteristic of cancer metabolism is Warburg effect formation that is the glucose metabolism in the glycolytic pathway in aerobic environments. Specific high expression of PKM2 (Pyruvate kinase type M2) is indispensable to the Warburg effect formation. Curcumin is an ingredient of Termeric, and has a variety of bioactivity with less toxicity. Recently, an anti-cancer effect of Curcumin attracts attention, and various studies are conducted to investigate the bio-mechanisms as an anti-cancer agent. While Curcumin has been reported to provide an anti-cancer effect by suppressing NF-κB-COX pathway and/or the oxidative stress, its effect on cancer metabolism still remains unclear. Here, we investigated the mechanism of anti-cancer effects derived by Curcumin by focusing on cancer metabolism. Method: The anti-cancer effect of Curcumin was examined by growth-assay in HCC cell lines (HepG2 and HLF). To further assess the biological mechanism of Curcumin on cancer cells, the changes in cancer metabolic pathways such as pyruvate kinase type M2 (PKM2), glucose transporter1 (Glut1), glucose-6-phosphate dehydrogenase deficiency (G6PD), and Transketolase (TKT). Result: In growth assay, Curcumin treatment significantly suppressed cell growth of HepG2 cell. For the cancer metabolic pathways, Curcumin treatment induced a shift into PKM1 from PKM2 expression represented by decreased PKM2/1 ratio by real time PCR in HepG2 and HLF cells. Indeed, Glut1 and G6PD expressions were also suppressed by Curcumin treatment, whereas TKT expression was increased in HepG2 cell. Conclusion: Curcumin displayed anti-proliferative effects on HCC cell lines, and its anti-cancer effects may be due to normalize the cancer metabolic pathway represented by a shift into PKM1 from PKM2 expression. Citation Format: Hideaki Takeyama, Hiromitsu Hayashi, Takayoshi Kaida, Kota Arima, Katsunobu Taki, Takaaki Higashi, Hirohisa Okabe, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Toru Beppu, Hideo Baba. Curcumin may have anticancer effect by normalizing cancer metabolic pathway. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1175. doi:10.1158/1538-7445.AM2015-1175
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 22 ( 2015-11-15), p. 4985-4997
    Abstract: Transcriptional coactivator with PDZ-binding motif (TAZ) and yes-associated protein (YAP) are equivalently placed downstream effectors of the Hippo pathway with oncogenic roles in human cancers. However, the expression profiles of TAZ/YAP differ depending on the cancer cell type, suggesting that these proteins have different roles during cancer progression, yet no studies have examined the biologic significance of the balance between TAZ and YAP expression levels. Here we examined the functional roles of TAZ/YAP in hepatocellular carcinoma progression. We found that TAZ, but not YAP, was predominantly expressed in HCC. TAZ knockdown under normal conditions attenuated cell growth in HCC cells; however, TAZ knockdown combined with 5-fluorouracil treatment significantly increased chemoresistance compared with control cells. Notably, TAZ knockdown induced compensatory YAP expression and was accompanied by upregulation of CD90, a HCC–specific cancer stem cell marker. Continuous treatment with 5-fluorouracil also induced YAP expression and promoted tumor formation in vivo. Conversely, double knockdown of TAZ/YAP reduced chemoresistance and tumorigenicity. Moreover, YAP knockdown aggravated HCC cell growth to a greater degree than TAZ knockdown, and YAP overexpression was strongly associated with poor prognoses in patients with HCC. Collectively, these studies demonstrate that TAZ and YAP exhibit different functional roles in cancer progression, and a shift to predominant YAP expression upon TAZ depletion conferred cancer stem cell–like properties including chemoresistance and tumorigenicity in HCC. Therefore, targeting of both TAZ/YAP will be required for a complete antitumor response in HCC. Cancer Res; 75(22); 4985–97. ©2015 AACR.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2013
    In:  Cancer Research Vol. 73, No. 8_Supplement ( 2013-04-15), p. 5188-5188
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 5188-5188
    Abstract: Background & Aims: Several studies reported that chronic pancreatitis (CP) is a risk factor for pancreatic ductal adenocarcinoma (PDAC). The loss-of-function mutations of serine protease inhibitor Kazal type 1 (SPINK1) gene are associated with various forms of hereditary pancreatitis.We previously showed that deletion of Spink3,the mouse homologue of human SPINK1, causes pancreatitis-like changes in the mouse. A careful molecular and pathological analysis of evolving PDAC has revealed a characteristic pattern of genetic lesions. The field is now faced with the challenge of understanding how these signature genetic lesions _ mutations of cancer-related genes _ contribute to the biological characteristics and evolution of this disease. The aim of this study was to rescue the Spink3−/- phenotype by generating Spink3−/- mice with knocked-in SPINK1, and to characterize time-dependent changes of cancer-related genes in the pancreas in this genetic model. Methods: We placed CAG promoter-SPINK1 minigene(SP1) into diaphanous homolog 2 (Diap2) locus, which is located on X chromosome, using the Cre-Lox technology. X-inactivation is a process whereby one of the two copies of the X chromosome present in female mammals is inactivated. By utilizing X-inactivation,we were able to create mice in which SPINK level was partially, but not completely, reduced compared with the wild type. The SP1 knock-in mice(male YXSP1 and female XSP1/SP1 or XSP1/+) were crossed to Spink3+/- mice, thus generating Spink3−/−SP1 knock-in mice. Mice were followed up for up to 6 months.Time-dependent changes in pancreatic histology, stellate cell activation, and serum amylase were measured. Results: Spink3−/−YXSP1,as well as Spink3−/−XSP1/SP1 mice in which SP1 transgene was present on both X chromosomes, showed no abnormalities in pancreas or any other organ during the 6 months of observation, indicating that human Spink1 rescues Spink3 deficiency in mice. Spink3−/−XSP1/+ mice in which SP1 transgene is present on only one of the two X chromosomes, showed slight growth retardation but were healthy and fertile. Pancreas of Spink3−/−XSP1/+ mice at birth contained both normal and degenerated acinar cells, with accumulation of autophagic vacuoles. The Spink3−/−XSP1/+ mice time-dependently developed pathologic features of chronic tissue damage, including loss of acinar cells, intralobular fibrosis with activated stellate cells. Interlobular ducts were dilated and contained protein plugs, which resembled chronic pancreatitis in human. Older mice displayed acinar-ductal metaplasia and prominent expression of proto-oncogenes Egfr, Her2, and Ras. Conclusions: CP may contribute to carcinogenesis by preventing the senescence barrier characteristic of normal pancreas. Antiinflammatory treatment of CP patients may reduce their risk of developing PDAC. Citation Format: Kazuya Sakata, Masaki Ohmuraya, Daisuke Hashimoto, Hidetoshi Nitta, Katunori Imai, Hiromitu Hayashi, Yoshiaki Ikuta, Akira Chikamoto, Tooru Beppu, Hideo Baba. Chronic pancreatitis induces the cancer-related gene expressions . [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5188. doi:10.1158/1538-7445.AM2013-5188
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 1160-1160
    Abstract: The contact inhibition of proliferation and cell movement is crucially important in embryonic development, tissue regeneration, and wound healing for the well-controlled organogenesis. The disruption of contact inhibition results in sustained cell proliferation and uncontrolled cell movement, which is a hallmark of solid tumors. Loss of contact inhibition allows cancer cells to facilitate the invasion of neighboring tissues and metastasis to remote organs. The recently identified Hippo signaling pathway has been implicated in contact inhibition of proliferation as well as organ size control. Indeed, the conditional inactivation of hippo-pathway in liver leads to enlarged liver (massive hepatomegaly) and tumorigenesis (Cell, 2007). Clinically, HCC often shows the huge tumor more than size in 10cm, strongly speculating that inactivation of hippo-pathway plays an important role in HCC progression. However, clinical significance of hippo-pathway in HCC is largely unknown. Here, we investigated the clinical significance of inactivated hippo-pathway, which induce overexpressed oncogenes (YAP/TAZ), using resected 80 HCC samples, and suggested the tumoral-high TAZmRNA expression was a worse prognostic biomarker for HCC patients represented by high proliferative activity. The tumor size in High TAZmRNA expression group (n =24) was significantly larger than that in low expression group (n = 56) (P & lt; 0.05). YAP/TAZ protein over-expression in HCC was associated with high proliferative activity by Ki-67 positive cells. The high TAZmRNA expression group showed significantly worsen disease free survival and overall survival compared with that in low expression group (P = 0.01 and 0.02, respectively). Thus, inactivation of Hippo-pathway plays a crucial role in tumor progression by accelerating proliferative activity, and tumoral TAZmRNA expression level may be a useful prognostic biomarker in HCC. Citation Format: Hiromitsu Hayashi, Hideyuki Kuroki, Naomi Yokoyama, Shigeki Nakagawa, Hidetoshi Nitta, Katsunori Imai, Daisuke Hashimoto, Yoshiaki Ikuta, Akira Chikamoto, Toru Beppu, Hideo Baba. Inactivated hippo-pathway as a prognostic biomarker in hepatocellular carcinoma. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1160. doi:10.1158/1538-7445.AM2013-1160
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 15_Supplement ( 2015-08-01), p. 4146-4146
    Abstract: Background: C5a is one of the important factors produced on complement pathway and a strong chemokine. There is emerging evidence that C5a is generated in the cancer microenvironment and C5a receptor (C5aR) is expressed in various cancer cells and associated with invasive ability in several cancer cells. However, the role of C5aR in gastric cancer (GC) is still mostly unknown. Aim: To investigate the clinical significance of C5aR expression in human GC. Method: 168 patients underwent gastrectomy after the diagnosis of gastric cancer from January 1st 2001 to December 31th 2009. C5aR-expression of GC cells was investigated in all 168 patients and was analyzed in regard to an association with clinicopathological factors and outcomes in the patients. Additionally, in vitro experiments were used to examine the proliferation and invasion of GC cells by using the GC cell lines that had high-expression of C5aR. Result: High-expression of C5aR was found in 55 patients (32.7%). High-expression of C5aR was significantly related to depth of invasion, stage, lymphatic and vascular invasion. Among the 146 patients with a tumor stage lower than stageIV, the 5-years recurrence-free and overall survival rates of patients in the high-expression of C5aR group were significantly lower than those in the low-expression of C5aR group (91.0% vs 52.4%, p = 0.007 and 87.2% vs 59.1%, p = 0.003, respectively). The high-expression of C5aR group had more frequently distant metastasis than the low-expression of C5aR group during the follow-up time, presenting itself mainly in liver metastasis and peritoneal dissemination (p = 0.020 and p = 0.026). We found that the gastric cancer cell lines MKN1 and MKN7 had the high-expression of C5aR with western blotting in vitro. Moreover, matrigel chamber assay revealed that 10 nM of recombinant C5a enhances cell invasiveness of MKN1 by 2.55-fold and the cell invasiveness of MKN7 by 2.90-fold, but such an enhancement by C5a was not observed in control cells. Conclusions: The gastric cancer patients with a high expression of C5aR were associated with poor prognosis, and the invasive ability of gastric cancer cell lines highly expressing of C5aR were promoted by C5a. Thus, targeting this C5a-C5aR axis might provide a useful therapeutic option for gastric cancer treatment. Citation Format: Takayoshi Kaida, Hidetoshi Nitta, Kota Arima, Hideaki Takeyama, Takaaki Higashi, Katunobu Taki, Hiromitsu Hayashi, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Toru Beppu, Hideo Baba. Overexpression of C5a receptor becomes risk factor in gastric cancer. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4146. doi:10.1158/1538-7445.AM2015-4146
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2014
    In:  Cancer Research Vol. 74, No. 19_Supplement ( 2014-10-01), p. 244-244
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 74, No. 19_Supplement ( 2014-10-01), p. 244-244
    Abstract: Background & Objective: Several studies reported that chronic pancreatitis is a risk factor for pancreatic ductal adenocarcinoma (PDAC). Serine protease inhibitor Kazal type 1 (SPINK1), also known as pancreatic secretory trypsin inhibitor (PSTI), was originally isolated from the pancreas. In mice, the homologous gene is designated as Spink3. SPINK1/Spink3 covalently can bind to activated trypsin within the pancreatic acinar cells to form an inactive and stable complex and to prevent acute pancreatitis, a major inflammatory disorder of the pancreas. The mutations of SPINK1 gene are associated with various forms of idiopathic pancreatitis. We previously showed that deletion of Spink3 causes pancreatitis-like changes in the mouse. A careful molecular and pathological analysis of this genetically engineered mouse model will reveal the chronic of nflammation in the pancreas. The aim of this study was to rescue the Spink3-/- phenotype by generating Spink3-/- mice with knocked-in SPINK1, and to analyze molecular mechanisms that initiate pancreatitis or drive its progression from acute to chronic disease in this genetic model. Methods: We placed SPINK1 minigene (KI) into mouse Spink3 locus, using the Cre-loxP technology and generated chimeric mice (Spink3KI/+). Spink3KI/+ mice were crossed to Spink3+/- mice, thus generating Spink3KI/-. Mice were followed up to 8 weeks old. Time-dependent changes in pancreatic histology, stellate cell ctivation, and serum amylase were measured. Results: Spink3KI/KI mice showed no abnormalities in pancreas or any other organ during the 8 weeks age of observation, indicating that human SPINK1 can rescue Spink3 deficiency in physiological condition. Spink3KI/- mice showed slight growth etardation. The pancreas of Spink3KI/- mice at birth contained normal acinar cells. The Spink3KI/- mice time-dependently developed pathologic features of chronic tissue damage, including loss of acinar cells, intralobular fibrosis with activated pancreatic stellate cells. Interlobular ducts were dilated and contained protein plugs, which resembled chronic pancreatitis in human. In the pancreas of Spink3KI/- mice, we found that trypsin activity increased, and large vacuoles, derived from autophagy, appeared in acinar cells. p62, which is a selective substrate for autophagy aggregated in acinar cells, suggested that autophagy is impaired in Spink3KI/- acinar cells. Conclusions: We demonstrated that SPINK1 insufficiency caused chronic pancreatitis in vivo. Impaired autophagy and high trypsin activity may contribute to cause chronic pancreatitis in human.We established chronic pancreatitis model in human SPINK1 knockin mice and identified shared pathological alterations in human and mouse chronic pancreatitis.Thus,this mouse model provides a suitable tool to analyze the oncogenesis from chronic pancreatitis. Citation Format: Kazuya Sakata, Masaki Ohmuraya, Katsunobu Taki, Daisuke Hashimoto, Satoshi Ida, Hidetoshi Nitta, Hiromitu Hayashi, Akira Chikamoto, Tooru Beppu, Hideo Baba. SPINK1 insufficiency induces impaired autophagy resulting in chronic pancreatitis. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 244. doi:10.1158/1538-7445.AM2014-244
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2014
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...